Adaptive Biotechnologies Corp Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Adaptive Biotechnologies Corp quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Adaptive Biotechnologies Corp Operating Margin for the quarter ending September 30, 2024 was -113 %, a 3.77% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Operating Margin for 2023 was -133 %, a 23.4% decline from 2022.
  • Adaptive Biotechnologies Corp annual Operating Margin for 2022 was -108 %, a 20.2% increase from 2021.
  • Adaptive Biotechnologies Corp annual Operating Margin for 2021 was -135 %, a 12.8% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -113 -4.09 -3.77% Jul 1, 2024 Sep 30, 2024
Q2 2024 -129 -29.2 -29.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -125 -19.9 -18.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -133 -25.3 -23.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -109 +23.9 +18% Jul 1, 2023 Sep 30, 2023
Q2 2023 -100 +46.2 +31.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -105 +43.9 +29.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -108 +27.4 +20.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -132 -1.76 -1.35% Jul 1, 2022 Sep 30, 2022
Q2 2022 -146 -17.1 -13.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -149 -11.8 -8.54% Jan 1, 2022 Mar 31, 2022
Q4 2021 -135 +19.9 +12.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -131 +13 +9.03% Jul 1, 2021 Sep 30, 2021
Q2 2021 -129 -5.71 -4.63% Apr 1, 2021 Jun 30, 2021
Q1 2021 -138 -38 -38.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -155 -63.2 -68.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -144 Jul 1, 2020 Sep 30, 2020
Q2 2020 -123 Apr 1, 2020 Jun 30, 2020
Q1 2020 -99.6 Jan 1, 2020 Mar 31, 2020
Q4 2019 -92.2 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.